Showing 1 - 12 results of 12 for search 'Ilva Lieknina', query time: 0.04s Refine Results
  1. 1
    Evaluation of Outer Surface Protein Vaccine Candidates of <i>Borrelia burgdorferi</i> for Lyme Disease

    Evaluation of Outer Surface Protein Vaccine Candidates of <i>Borrelia burgdorferi</i> for Lyme Disease by Ilva Liekniņa, Anna Kozlova, Marina Šaško, Ināra Akopjana, Kalvis Brangulis, Kaspars Tārs

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data

    Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data by Ilva Liekniņa, Gints Kalniņš, Ināra Akopjana, Jānis Bogans, Mihails Šišovs, Juris Jansons, Jānis Rūmnieks, Kaspars Tārs

    Published 2019-05-01
    Get full text
    Article
  3. 3
    Production of the HBc Protein from Different HBV Genotypes in <i>E. coli</i>. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA

    Production of the HBc Protein from Different HBV Genotypes in <i>E. coli</i>. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA by Ivars Petrovskis, Ilva Lieknina, Andris Dislers, Juris Jansons, Janis Bogans, Inara Akopjana, Jelena Zakova, Irina Sominskaya

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

    Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles. by Dace Skrastina, Ivars Petrovskis, Ilva Lieknina, Janis Bogans, Regina Renhofa, Velta Ose, Andris Dishlers, Yuri Dekhtyar, Paul Pumpens

    Published 2014-01-01
    Get full text
    Article
  5. 5
    PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine

    PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine by Andris Dishlers, Ivars Petrovskis, Dace Skrastina, Ieva Zarina, Ilva Lieknina, Juris Jansons, Inara Akopjana, Jelena Zakova, Velta Ose, Irina Sominskaya

    Published 2023-04-01
    Get full text
    Article
  6. 6
    Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2

    Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2 by Ilva Liekniņa, Lasse Reimer, Teodors Panteļejevs, Alons Lends, Kristaps Jaudzems, Aadil El-Turabi, Hjalte Gram, Anissa Hammi, Poul Henning Jensen, Kaspars Tārs

    Published 2024-10-01
    Get full text
    Article
  7. 7
    Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Disease Vaccine

    Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Disease Vaccine by Ashley L. Marcinkiewicz, Ilva Lieknina, Svetlana Kotelovica, Xiuli Yang, Peter Kraiczy, Utpal Pal, Yi-Pin Lin, Yi-Pin Lin, Kaspars Tars, Kaspars Tars

    Published 2018-02-01
    Get full text
    Article
  8. 8
    Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5′ Terminus of Hepatitis C Virus RNA

    Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5′ Terminus of Hepatitis C Virus RNA by Irina Sominskaya, Juris Jansons, Anastasija Dovbenko, Natalia Petrakova, Ilva Lieknina, Marija Mihailova, Oleg Latyshev, Olesja Eliseeva, Irina Stahovska, Inara Akopjana, Ivars Petrovskis, Maria Isaguliants

    Published 2015-01-01
    Get full text
    Article
  9. 9
    Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens

    Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens by Anna Kirsteina, Inara Akopjana, Janis Bogans, Ilva Lieknina, Juris Jansons, Dace Skrastina, Tatjana Kazaka, Kaspars Tars, Irina Isakova-Sivak, Daria Mezhenskaya, Tatiana Kotomina, Victoria Matyushenko, Larisa Rudenko, Andris Kazaks

    Published 2020-04-01
    Get full text
    Article
  10. 10
    Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874

    Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. <i>Vaccines</i> 2024, <i>12</i>, 874 by Dominik A. Rothen, Sudip Kumar Dutta, Pascal S. Krenger, Anne-Cathrine S. Vogt, Ilva Lieknina, Jan M. Sobczak, Albert D. M. E. Osterhaus, Mona O. Mohsen, Monique Vogel, Byron Martina, Kaspars Tars, Martin F. Bachmann

    Published 2024-10-01
    Get full text
    Article
  11. 11
    Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes

    Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes by Dominik A. Rothen, Sudip Kumar Dutta, Pascal S. Krenger, Anne-Cathrine S. Vogt, Ilva Lieknina, Jan M. Sobczak, Albert D. M. E. Osterhaus, Mona O. Mohsen, Monique Vogel, Byron Martina, Kaspars Tars, Martin F. Bachmann

    Published 2024-08-01
    Get full text
    Article
  12. 12
    Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines

    Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines by Dominik A. Rothen, Sudip Kumar Dutta, Pascal S. Krenger, Alessandro Pardini, Anne-Cathrine S. Vogt, Romano Josi, Ilva Lieknina, Albert D. M. E. Osterhaus, Mona O. Mohsen, Monique Vogel, Byron Martina, Kaspars Tars, Martin F. Bachmann

    Published 2024-09-01
    Get full text
    Article

Search Tools: